Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Antidepressant Drugs: Overview

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Treatment Resistent Cancers

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Vestibular self-motion perception in a patient with bilateral thalamic infarction.

Journal of neurology·2025

Same author

Rapid point-of-care detection of SARS-CoV-2 infection in exhaled breath using ion mobility spectrometry: a pilot study.

European journal of medical research·2023

Same author

Systematic Radiation Dose Reduction in Cervical Spine CT of Human Cadaveric Specimens: How Low Can We Go?

AJNR. American journal of neuroradiology·2017

Same author

[Osler's disease].

Der Radiologe·2013

Same author

Linear erosive herpes simplex virus: the 'knife-cut sign' in a patient on high-dose corticosteroids.

Clinical and experimental dermatology·2010

Same author

The paradoxical advantages and disadvantages of natural selection: the case history of Charles Darwin.

Medical hypotheses·2007

Search research articles

Related Experiment Video

Updated: May 25, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Defeating cancer with antidepressants.

¹127 Cumberland Road, Burlington, Vermont, USA. julianlieb@aol.com

Ecancermedicalscience

|January 26, 2012

Summary

This summary is machine-generated.

Antidepressants may inhibit prostaglandins, crucial cell regulators involved in mood, immunity, and cancer. This research explores their potential as anti-cancer agents by targeting prostaglandin synthesis.

Related Experiment Videos

Last Updated: May 25, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Area of Science:

Biochemistry
Cell Biology
Immunology

Background:

Prostaglandins are vital signaling molecules regulating cellular functions, including mood and immunity.
Dysregulation of prostaglandin synthesis is linked to immune suppression and cancer development.
Current understanding positions prostaglandins as key players in both cellular health and disease.

Purpose of the Study:

To investigate the potential of antidepressants as anti-cancer agents.
To explore the mechanism by which antidepressants might inhibit prostaglandin synthesis.
To determine if antidepressants can disrupt cancer pathogenesis by modulating prostaglandin activity.

Main Methods:

Review of existing literature on prostaglandins and antidepressant pharmacology.
Analysis of biochemical pathways involved in prostaglandin synthesis and regulation.
Hypothetical modeling of antidepressant interactions with prostaglandin-related cellular processes.

Main Results:

Prostaglandins play a paradoxical role in cell function and dysfunction.
Excessive prostaglandin production is associated with impaired immunity and cancer.
Antidepressants exhibit properties that suggest potential for inhibiting harmful prostaglandin synthesis.

Conclusions:

Antidepressants possess characteristics that could be leveraged for cancer therapy.
Targeting prostaglandin synthesis with antidepressants offers a novel anti-cancer strategy.
Further research is warranted to validate the anti-cancer efficacy of antidepressants.